| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Platelet Glycoprotein GPIIb-IIIa Complex | 17 | 2010 | 34 | 3.090 |
Why?
|
| Fibrin | 26 | 2012 | 33 | 1.720 |
Why?
|
| Blood Platelets | 22 | 2013 | 59 | 1.640 |
Why?
|
| Fibrinogen | 25 | 2012 | 66 | 1.630 |
Why?
|
| Platelet Aggregation Inhibitors | 8 | 2009 | 79 | 1.120 |
Why?
|
| Peptides | 8 | 2010 | 128 | 1.120 |
Why?
|
| Protein Conformation | 20 | 2012 | 110 | 0.960 |
Why?
|
| Fibrinolysis | 7 | 2005 | 13 | 0.760 |
Why?
|
| Platelet Membrane Glycoproteins | 13 | 1995 | 18 | 0.690 |
Why?
|
| Oligopeptides | 8 | 2004 | 48 | 0.680 |
Why?
|
| Models, Molecular | 12 | 2013 | 204 | 0.660 |
Why?
|
| Protein Binding | 18 | 2013 | 243 | 0.650 |
Why?
|
| Platelet Adhesiveness | 8 | 2002 | 21 | 0.550 |
Why?
|
| Recombinant Proteins | 12 | 2012 | 263 | 0.530 |
Why?
|
| Surface Plasmon Resonance | 6 | 2013 | 17 | 0.520 |
Why?
|
| Ligands | 10 | 2013 | 90 | 0.400 |
Why?
|
| Entropy | 3 | 2010 | 11 | 0.400 |
Why?
|
| Platelet Aggregation | 10 | 2004 | 30 | 0.380 |
Why?
|
| Intercellular Signaling Peptides and Proteins | 6 | 2009 | 100 | 0.370 |
Why?
|
| Blood Coagulation | 4 | 2013 | 15 | 0.360 |
Why?
|
| Peptide Fragments | 9 | 2012 | 417 | 0.360 |
Why?
|
| Kinetics | 18 | 2009 | 248 | 0.350 |
Why?
|
| Protein Structure, Tertiary | 11 | 2013 | 113 | 0.340 |
Why?
|
| Thrombin | 10 | 2001 | 25 | 0.330 |
Why?
|
| Amino Acid Sequence | 14 | 2013 | 293 | 0.320 |
Why?
|
| Humans | 57 | 2016 | 32284 | 0.320 |
Why?
|
| Tyrosine | 3 | 2009 | 24 | 0.320 |
Why?
|
| Integrins | 4 | 2009 | 16 | 0.320 |
Why?
|
| Receptors, Cell Surface | 3 | 2003 | 78 | 0.320 |
Why?
|
| Binding Sites | 11 | 2013 | 143 | 0.320 |
Why?
|
| Scattering, Radiation | 12 | 2006 | 17 | 0.310 |
Why?
|
| Dual Specificity Phosphatase 2 | 1 | 2009 | 1 | 0.300 |
Why?
|
| Light | 11 | 2006 | 34 | 0.300 |
Why?
|
| Platelet Activation | 4 | 2006 | 16 | 0.300 |
Why?
|
| Thrombosis | 4 | 2001 | 78 | 0.290 |
Why?
|
| Integrin alphaVbeta3 | 1 | 2008 | 4 | 0.280 |
Why?
|
| Isoxazoles | 3 | 2009 | 7 | 0.270 |
Why?
|
| Thermodynamics | 4 | 2010 | 57 | 0.270 |
Why?
|
| Membrane Glycoproteins | 2 | 2003 | 112 | 0.260 |
Why?
|
| Flagellin | 2 | 2008 | 38 | 0.260 |
Why?
|
| Microscopy, Electron | 11 | 2004 | 44 | 0.260 |
Why?
|
| Antibodies, Monoclonal | 10 | 2001 | 246 | 0.250 |
Why?
|
| Endothelium, Vascular | 3 | 2004 | 153 | 0.250 |
Why?
|
| Plasminogen Activator Inhibitor 1 | 3 | 1996 | 42 | 0.240 |
Why?
|
| Animals | 25 | 2013 | 8165 | 0.230 |
Why?
|
| Mutation | 8 | 2013 | 497 | 0.220 |
Why?
|
| Postural Balance | 1 | 2016 | 142 | 0.210 |
Why?
|
| Dimerization | 7 | 2006 | 30 | 0.210 |
Why?
|
| Pesticides | 1 | 2016 | 135 | 0.210 |
Why?
|
| Occupational Exposure | 1 | 2016 | 159 | 0.210 |
Why?
|
| Transients and Migrants | 1 | 2016 | 197 | 0.200 |
Why?
|
| Endothelial Cells | 1 | 2005 | 190 | 0.200 |
Why?
|
| Adenosine Diphosphate | 6 | 1992 | 11 | 0.200 |
Why?
|
| Peptides, Cyclic | 2 | 2006 | 6 | 0.200 |
Why?
|
| Emigrants and Immigrants | 1 | 2016 | 198 | 0.200 |
Why?
|
| Molecular Sequence Data | 10 | 2013 | 368 | 0.190 |
Why?
|
| Enterobacteriaceae | 1 | 2003 | 14 | 0.190 |
Why?
|
| Keratins | 2 | 2013 | 39 | 0.190 |
Why?
|
| von Willebrand Factor | 3 | 1995 | 16 | 0.190 |
Why?
|
| Ephrin-A1 | 2 | 2013 | 12 | 0.190 |
Why?
|
| Receptor, EphA2 | 2 | 2013 | 15 | 0.190 |
Why?
|
| Hemostatics | 2 | 2013 | 13 | 0.180 |
Why?
|
| Temperature | 6 | 2008 | 58 | 0.180 |
Why?
|
| Amino Acids | 4 | 2006 | 52 | 0.170 |
Why?
|
| Molecular Weight | 7 | 2006 | 55 | 0.170 |
Why?
|
| Biocompatible Materials | 2 | 2013 | 240 | 0.170 |
Why?
|
| Hispanic Americans | 1 | 2016 | 772 | 0.170 |
Why?
|
| Ribosomes | 1 | 2000 | 11 | 0.170 |
Why?
|
| Mitochondria, Liver | 1 | 2000 | 6 | 0.170 |
Why?
|
| Solutions | 6 | 2011 | 39 | 0.150 |
Why?
|
| Fibrinogens, Abnormal | 4 | 2001 | 4 | 0.150 |
Why?
|
| Protein Structure, Secondary | 7 | 2012 | 60 | 0.150 |
Why?
|
| Blood Coagulation Tests | 2 | 1998 | 8 | 0.150 |
Why?
|
| Cell Proliferation | 3 | 2013 | 599 | 0.150 |
Why?
|
| Nuclear Magnetic Resonance, Biomolecular | 3 | 2008 | 24 | 0.150 |
Why?
|
| Signal Transduction | 3 | 2013 | 716 | 0.140 |
Why?
|
| Circular Dichroism | 6 | 2012 | 39 | 0.140 |
Why?
|
| Crystallography, X-Ray | 5 | 2013 | 87 | 0.140 |
Why?
|
| Pipecolic Acids | 1 | 1998 | 7 | 0.140 |
Why?
|
| Amidines | 2 | 2009 | 4 | 0.140 |
Why?
|
| Mesylates | 1 | 1998 | 2 | 0.140 |
Why?
|
| Cell Membrane | 6 | 2012 | 109 | 0.140 |
Why?
|
| Protein Multimerization | 3 | 2013 | 25 | 0.140 |
Why?
|
| Receptors, Peptide | 2 | 1988 | 8 | 0.140 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2001 | 46 | 0.130 |
Why?
|
| Cell Line | 4 | 2005 | 443 | 0.130 |
Why?
|
| Cells, Cultured | 5 | 2013 | 821 | 0.130 |
Why?
|
| Dose-Response Relationship, Drug | 4 | 2006 | 709 | 0.130 |
Why?
|
| Binding, Competitive | 4 | 2013 | 41 | 0.120 |
Why?
|
| Fibrinolytic Agents | 2 | 1996 | 63 | 0.120 |
Why?
|
| Capsid | 1 | 1996 | 8 | 0.120 |
Why?
|
| Viral Matrix Proteins | 1 | 1996 | 12 | 0.120 |
Why?
|
| Vesicular stomatitis Indiana virus | 1 | 1996 | 16 | 0.120 |
Why?
|
| Models, Biological | 5 | 2008 | 403 | 0.120 |
Why?
|
| Hemostasis | 2 | 2013 | 8 | 0.120 |
Why?
|
| Transfection | 4 | 2006 | 198 | 0.120 |
Why?
|
| Ultracentrifugation | 3 | 2006 | 8 | 0.120 |
Why?
|
| Protein Structure, Quaternary | 3 | 2011 | 22 | 0.110 |
Why?
|
| Microscopy, Electron, Scanning | 6 | 2013 | 102 | 0.110 |
Why?
|
| Bacterial Proteins | 2 | 2008 | 99 | 0.110 |
Why?
|
| Protein Denaturation | 4 | 2004 | 16 | 0.110 |
Why?
|
| Cattle | 8 | 2012 | 118 | 0.110 |
Why?
|
| Cholesterol Esters | 2 | 2013 | 37 | 0.110 |
Why?
|
| Time Factors | 6 | 2008 | 2196 | 0.100 |
Why?
|
| Adult | 9 | 2016 | 9263 | 0.100 |
Why?
|
| Microscopy, Fluorescence | 4 | 2008 | 93 | 0.100 |
Why?
|
| Proteoglycans | 1 | 2013 | 34 | 0.100 |
Why?
|
| Centrifugation, Density Gradient | 2 | 2004 | 12 | 0.100 |
Why?
|
| Hair | 1 | 2013 | 27 | 0.090 |
Why?
|
| Interleukin-13 Receptor alpha1 Subunit | 1 | 2012 | 11 | 0.090 |
Why?
|
| Interleukin-13 Receptor alpha2 Subunit | 1 | 2012 | 12 | 0.090 |
Why?
|
| Cholesterol, LDL | 1 | 2013 | 170 | 0.090 |
Why?
|
| Interleukin-13 | 1 | 2012 | 29 | 0.090 |
Why?
|
| Water | 2 | 2008 | 65 | 0.090 |
Why?
|
| Elasticity | 5 | 2008 | 41 | 0.090 |
Why?
|
| Hydrogels | 1 | 2013 | 125 | 0.090 |
Why?
|
| Oxo-Acid-Lyases | 1 | 2011 | 3 | 0.090 |
Why?
|
| Protein Subunits | 2 | 2002 | 40 | 0.090 |
Why?
|
| Microscopy, Atomic Force | 3 | 2008 | 8 | 0.090 |
Why?
|
| Hyperoxaluria, Primary | 1 | 2011 | 8 | 0.090 |
Why?
|
| Hydroxyproline | 1 | 2011 | 10 | 0.090 |
Why?
|
| Receptors, Very Late Antigen | 1 | 1991 | 1 | 0.090 |
Why?
|
| G-Quadruplexes | 1 | 2011 | 9 | 0.090 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2011 | 10 | 0.080 |
Why?
|
| Alanine | 2 | 2012 | 30 | 0.080 |
Why?
|
| Glioblastoma | 1 | 2012 | 158 | 0.080 |
Why?
|
| Platelet Glycoprotein GPIb-IX Complex | 1 | 1990 | 5 | 0.080 |
Why?
|
| Immunoglobulin Fab Fragments | 2 | 2001 | 14 | 0.080 |
Why?
|
| DNA | 1 | 2011 | 222 | 0.080 |
Why?
|
| Solubility | 2 | 2004 | 39 | 0.080 |
Why?
|
| Octoxynol | 3 | 2006 | 9 | 0.080 |
Why?
|
| Spectrometry, Mass, Matrix-Assisted Laser Desorption-Ionization | 2 | 2006 | 20 | 0.080 |
Why?
|
| Liposomes | 2 | 2008 | 35 | 0.070 |
Why?
|
| Gene Expression Regulation | 1 | 2012 | 478 | 0.070 |
Why?
|
| Fluorescence Polarization | 2 | 2006 | 2 | 0.070 |
Why?
|
| Cell Line, Tumor | 4 | 2013 | 726 | 0.070 |
Why?
|
| Plague Vaccine | 1 | 2008 | 3 | 0.070 |
Why?
|
| Pore Forming Cytotoxic Proteins | 1 | 2008 | 7 | 0.070 |
Why?
|
| Antigens, Bacterial | 1 | 2008 | 24 | 0.070 |
Why?
|
| Disulfides | 5 | 2012 | 43 | 0.070 |
Why?
|
| Phosphatidylinositols | 1 | 2008 | 6 | 0.070 |
Why?
|
| Materials Testing | 1 | 2008 | 89 | 0.070 |
Why?
|
| Fibronectins | 1 | 2008 | 40 | 0.070 |
Why?
|
| Haptoglobins | 1 | 2008 | 5 | 0.070 |
Why?
|
| Structure-Activity Relationship | 2 | 2006 | 88 | 0.070 |
Why?
|
| Hemoglobins | 1 | 2008 | 45 | 0.070 |
Why?
|
| Blotting, Western | 3 | 2013 | 297 | 0.070 |
Why?
|
| Biosensing Techniques | 1 | 2008 | 24 | 0.070 |
Why?
|
| Toll-Like Receptor 5 | 2 | 2008 | 11 | 0.070 |
Why?
|
| Nitric Oxide | 1 | 2008 | 119 | 0.060 |
Why?
|
| Atherosclerosis | 1 | 2013 | 806 | 0.060 |
Why?
|
| Sequence Homology, Amino Acid | 3 | 2013 | 77 | 0.060 |
Why?
|
| Platelet Function Tests | 1 | 2006 | 7 | 0.060 |
Why?
|
| Pyrrolidines | 1 | 2006 | 15 | 0.060 |
Why?
|
| Brain Neoplasms | 1 | 2012 | 636 | 0.060 |
Why?
|
| Hydrolysis | 4 | 1999 | 41 | 0.060 |
Why?
|
| Injections, Intravenous | 1 | 2006 | 98 | 0.060 |
Why?
|
| Arginine | 2 | 1998 | 23 | 0.060 |
Why?
|
| Biotinylation | 1 | 2006 | 12 | 0.060 |
Why?
|
| Proteins | 1 | 2007 | 147 | 0.060 |
Why?
|
| Reference Values | 1 | 2006 | 238 | 0.060 |
Why?
|
| Administration, Oral | 1 | 2006 | 201 | 0.060 |
Why?
|
| Mice | 5 | 2013 | 2544 | 0.060 |
Why?
|
| Mass Spectrometry | 3 | 2013 | 98 | 0.060 |
Why?
|
| Apolipoproteins B | 1 | 2006 | 48 | 0.060 |
Why?
|
| Receptors, Eicosanoid | 1 | 2005 | 5 | 0.060 |
Why?
|
| Arachidonic Acids | 1 | 2005 | 27 | 0.060 |
Why?
|
| Lipoproteins | 1 | 2006 | 92 | 0.060 |
Why?
|
| Lipid Metabolism | 1 | 2006 | 104 | 0.060 |
Why?
|
| Biophysics | 2 | 2007 | 13 | 0.050 |
Why?
|
| Biophysical Phenomena | 2 | 2007 | 10 | 0.050 |
Why?
|
| Viper Venoms | 1 | 2004 | 1 | 0.050 |
Why?
|
| Hemoglobin A | 1 | 2004 | 2 | 0.050 |
Why?
|
| Potassium Compounds | 1 | 2004 | 2 | 0.050 |
Why?
|
| Micromanipulation | 1 | 2004 | 3 | 0.050 |
Why?
|
| Hemoglobin, Sickle | 1 | 2004 | 9 | 0.050 |
Why?
|
| Clot Retraction | 2 | 1995 | 2 | 0.050 |
Why?
|
| Phosphates | 1 | 2004 | 26 | 0.050 |
Why?
|
| Escherichia coli | 2 | 2006 | 103 | 0.050 |
Why?
|
| Chromatography, Affinity | 1 | 2004 | 15 | 0.050 |
Why?
|
| Rheology | 2 | 2013 | 35 | 0.050 |
Why?
|
| Male | 5 | 2016 | 19434 | 0.050 |
Why?
|
| Heterozygote | 2 | 2001 | 60 | 0.050 |
Why?
|
| Female | 6 | 2016 | 19954 | 0.050 |
Why?
|
| Case-Control Studies | 1 | 2016 | 858 | 0.050 |
Why?
|
| Spectrometry, Fluorescence | 2 | 2001 | 32 | 0.050 |
Why?
|
| Computer Simulation | 3 | 2008 | 251 | 0.050 |
Why?
|
| Centrifugation | 1 | 2003 | 4 | 0.050 |
Why?
|
| COS Cells | 1 | 2003 | 31 | 0.050 |
Why?
|
| Toll-Like Receptors | 1 | 2003 | 30 | 0.050 |
Why?
|
| Phosphatidylcholines | 3 | 1999 | 29 | 0.050 |
Why?
|
| Magnetic Resonance Spectroscopy | 3 | 2008 | 93 | 0.050 |
Why?
|
| Hot Temperature | 1 | 2002 | 81 | 0.050 |
Why?
|
| Hydroxyl Radical | 1 | 2002 | 3 | 0.050 |
Why?
|
| Streptococcus mutans | 1 | 2002 | 5 | 0.050 |
Why?
|
| Cysteine | 2 | 2001 | 145 | 0.050 |
Why?
|
| Receptor Aggregation | 1 | 2002 | 2 | 0.050 |
Why?
|
| Nephelometry and Turbidimetry | 1 | 2002 | 3 | 0.050 |
Why?
|
| Mathematics | 4 | 1993 | 13 | 0.050 |
Why?
|
| Protein Interaction Mapping | 1 | 2002 | 10 | 0.050 |
Why?
|
| Cadaverine | 1 | 1982 | 1 | 0.050 |
Why?
|
| Diamines | 1 | 1982 | 1 | 0.050 |
Why?
|
| Mutagenesis, Site-Directed | 2 | 2012 | 64 | 0.050 |
Why?
|
| Serine Endopeptidases | 2 | 1992 | 19 | 0.040 |
Why?
|
| North Carolina | 1 | 2016 | 1299 | 0.040 |
Why?
|
| Microscopy, Immunoelectron | 4 | 1995 | 7 | 0.040 |
Why?
|
| Peroxidases | 1 | 2002 | 36 | 0.040 |
Why?
|
| Stress, Mechanical | 3 | 2007 | 95 | 0.040 |
Why?
|
| Umbilical Veins | 2 | 2004 | 13 | 0.040 |
Why?
|
| Iron | 1 | 2002 | 93 | 0.040 |
Why?
|
| Models, Chemical | 3 | 2002 | 33 | 0.040 |
Why?
|
| Cell Adhesion | 3 | 2013 | 95 | 0.040 |
Why?
|
| Cytoplasm | 1 | 2001 | 29 | 0.040 |
Why?
|
| Fibrinolysin | 3 | 2001 | 5 | 0.040 |
Why?
|
| Vaccinia virus | 1 | 2001 | 19 | 0.040 |
Why?
|
| Cloning, Molecular | 1 | 2001 | 77 | 0.040 |
Why?
|
| Gene Deletion | 1 | 2001 | 66 | 0.040 |
Why?
|
| Antioxidants | 1 | 2002 | 119 | 0.040 |
Why?
|
| Carrier Proteins | 1 | 2002 | 148 | 0.040 |
Why?
|
| Perfusion | 2 | 1998 | 75 | 0.040 |
Why?
|
| Postprandial Period | 1 | 2001 | 10 | 0.040 |
Why?
|
| Biopolymers | 1 | 2001 | 8 | 0.040 |
Why?
|
| RNA, Ribosomal | 1 | 2000 | 2 | 0.040 |
Why?
|
| Flow Cytometry | 1 | 2001 | 184 | 0.040 |
Why?
|
| Diffusion | 1 | 2000 | 17 | 0.040 |
Why?
|
| Apolipoproteins A | 1 | 2001 | 27 | 0.040 |
Why?
|
| Histidine | 2 | 2006 | 7 | 0.040 |
Why?
|
| Thrombolytic Therapy | 2 | 2001 | 63 | 0.040 |
Why?
|
| Polymorphism, Genetic | 1 | 2001 | 179 | 0.040 |
Why?
|
| Detergents | 2 | 2006 | 17 | 0.040 |
Why?
|
| Triglycerides | 1 | 2001 | 234 | 0.040 |
Why?
|
| Image Processing, Computer-Assisted | 3 | 2012 | 232 | 0.040 |
Why?
|
| Phospholipases | 1 | 1999 | 2 | 0.040 |
Why?
|
| Phospholipids | 1 | 1999 | 32 | 0.040 |
Why?
|
| Streptokinase | 1 | 1998 | 1 | 0.040 |
Why?
|
| Chickens | 2 | 2008 | 36 | 0.030 |
Why?
|
| Rats, Sprague-Dawley | 1 | 2000 | 896 | 0.030 |
Why?
|
| Calcium | 1 | 2000 | 337 | 0.030 |
Why?
|
| Sulfonamides | 1 | 1998 | 85 | 0.030 |
Why?
|
| Micelles | 2 | 1999 | 7 | 0.030 |
Why?
|
| von Willebrand Diseases | 3 | 1995 | 3 | 0.030 |
Why?
|
| Macromolecular Substances | 2 | 1996 | 18 | 0.030 |
Why?
|
| Coculture Techniques | 1 | 1998 | 75 | 0.030 |
Why?
|
| Lipase | 1 | 1997 | 30 | 0.030 |
Why?
|
| Lipids | 1 | 1999 | 250 | 0.030 |
Why?
|
| Columbidae | 2 | 1994 | 3 | 0.030 |
Why?
|
| Rats | 1 | 2000 | 1892 | 0.030 |
Why?
|
| Coronary Thrombosis | 1 | 1996 | 12 | 0.030 |
Why?
|
| Cricetinae | 1 | 1996 | 49 | 0.030 |
Why?
|
| Sodium Chloride | 1 | 1996 | 25 | 0.030 |
Why?
|
| Substrate Specificity | 2 | 2011 | 80 | 0.030 |
Why?
|
| Drug Resistance | 1 | 1996 | 42 | 0.030 |
Why?
|
| Viscosity | 2 | 2008 | 25 | 0.030 |
Why?
|
| Drug Administration Schedule | 1 | 1996 | 276 | 0.030 |
Why?
|
| Buffers | 2 | 2006 | 11 | 0.030 |
Why?
|
| Lipoproteins, HDL | 1 | 1997 | 247 | 0.030 |
Why?
|
| Chromatography, Gel | 2 | 1993 | 16 | 0.030 |
Why?
|
| Gels | 1 | 1995 | 31 | 0.030 |
Why?
|
| Microscopy, Video | 2 | 2007 | 7 | 0.030 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 2 | 1985 | 22 | 0.030 |
Why?
|
| Oxygen | 2 | 2008 | 134 | 0.030 |
Why?
|
| Liver | 1 | 1997 | 491 | 0.030 |
Why?
|
| Ribonucleases | 1 | 1974 | 7 | 0.030 |
Why?
|
| Spectrophotometry, Ultraviolet | 2 | 1990 | 18 | 0.030 |
Why?
|
| Glutathione | 1 | 1974 | 38 | 0.030 |
Why?
|
| Point Mutation | 1 | 1994 | 29 | 0.030 |
Why?
|
| Carbohydrate Sequence | 1 | 1993 | 1 | 0.030 |
Why?
|
| Models, Structural | 1 | 1993 | 5 | 0.030 |
Why?
|
| Thrombasthenia | 2 | 1995 | 2 | 0.030 |
Why?
|
| Enzyme-Linked Immunosorbent Assay | 2 | 1993 | 151 | 0.030 |
Why?
|
| Pancreas | 1 | 1974 | 107 | 0.030 |
Why?
|
| Antigens | 1 | 1993 | 34 | 0.020 |
Why?
|
| Batroxobin | 2 | 1985 | 2 | 0.020 |
Why?
|
| Ephrin-A2 | 1 | 2013 | 3 | 0.020 |
Why?
|
| Glycosylation | 1 | 2013 | 15 | 0.020 |
Why?
|
| Glucosides | 1 | 1993 | 13 | 0.020 |
Why?
|
| Colorimetry | 1 | 2013 | 4 | 0.020 |
Why?
|
| Polyethylene Glycols | 1 | 1993 | 63 | 0.020 |
Why?
|
| Electrophoresis | 1 | 2013 | 8 | 0.020 |
Why?
|
| Aged | 1 | 2016 | 10257 | 0.020 |
Why?
|
| Arteries | 1 | 2013 | 75 | 0.020 |
Why?
|
| Stereoisomerism | 1 | 1992 | 26 | 0.020 |
Why?
|
| Microscopy, Confocal | 1 | 2013 | 73 | 0.020 |
Why?
|
| Monocytes | 1 | 1993 | 118 | 0.020 |
Why?
|
| Chromatography, Thin Layer | 1 | 2012 | 9 | 0.020 |
Why?
|
| Electrophoretic Mobility Shift Assay | 1 | 2012 | 19 | 0.020 |
Why?
|
| Immunoenzyme Techniques | 1 | 2012 | 47 | 0.020 |
Why?
|
| Macrophages | 1 | 1993 | 164 | 0.020 |
Why?
|
| Cell Movement | 1 | 2013 | 165 | 0.020 |
Why?
|
| Polymers | 3 | 2001 | 65 | 0.020 |
Why?
|
| Xenograft Model Antitumor Assays | 1 | 2012 | 114 | 0.020 |
Why?
|
| Swine | 1 | 2013 | 229 | 0.020 |
Why?
|
| Mutagenesis | 1 | 2012 | 34 | 0.020 |
Why?
|
| Middle Aged | 1 | 2016 | 11843 | 0.020 |
Why?
|
| Protein Isoforms | 1 | 2012 | 60 | 0.020 |
Why?
|
| Apoenzymes | 1 | 2011 | 3 | 0.020 |
Why?
|
| Schiff Bases | 1 | 2011 | 3 | 0.020 |
Why?
|
| Mice, Nude | 1 | 2012 | 285 | 0.020 |
Why?
|
| Pyruvic Acid | 1 | 2011 | 6 | 0.020 |
Why?
|
| Catalytic Domain | 1 | 2011 | 68 | 0.020 |
Why?
|
| Chymotrypsin | 1 | 1991 | 1 | 0.020 |
Why?
|
| Positron-Emission Tomography | 1 | 2012 | 167 | 0.020 |
Why?
|
| Trypsin | 1 | 1991 | 10 | 0.020 |
Why?
|
| Recombinases | 1 | 2011 | 2 | 0.020 |
Why?
|
| Peptide Nucleic Acids | 1 | 2011 | 4 | 0.020 |
Why?
|
| Genes, myc | 1 | 2011 | 6 | 0.020 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2011 | 20 | 0.020 |
Why?
|
| Oligodeoxyribonucleotides | 1 | 2011 | 17 | 0.020 |
Why?
|
| Bacteria | 1 | 2011 | 55 | 0.020 |
Why?
|
| Cardiolipins | 1 | 1990 | 3 | 0.020 |
Why?
|
| Mitochondria, Heart | 1 | 1990 | 17 | 0.020 |
Why?
|
| Proton-Translocating ATPases | 1 | 1990 | 17 | 0.020 |
Why?
|
| Electrophoresis, Polyacrylamide Gel | 3 | 2001 | 43 | 0.020 |
Why?
|
| Antibody Specificity | 1 | 1990 | 17 | 0.020 |
Why?
|
| Iodine Radioisotopes | 1 | 1990 | 22 | 0.020 |
Why?
|
| Cytophotometry | 1 | 1990 | 1 | 0.020 |
Why?
|
| Integrin alpha2 | 1 | 1990 | 1 | 0.020 |
Why?
|
| Receptors, Immunologic | 1 | 1990 | 21 | 0.020 |
Why?
|
| Regenerative Medicine | 1 | 2013 | 216 | 0.020 |
Why?
|
| Protein Stability | 1 | 2009 | 26 | 0.020 |
Why?
|
| Mitochondria | 1 | 2011 | 207 | 0.020 |
Why?
|
| Yersinia pestis | 1 | 2008 | 3 | 0.020 |
Why?
|
| Drug Stability | 1 | 2008 | 11 | 0.020 |
Why?
|
| Drug Storage | 1 | 2008 | 5 | 0.020 |
Why?
|
| Virulence Factors | 1 | 2008 | 14 | 0.020 |
Why?
|
| Immunization, Secondary | 1 | 2008 | 13 | 0.020 |
Why?
|
| Blood Flow Velocity | 2 | 2001 | 77 | 0.020 |
Why?
|
| Antibodies, Bacterial | 1 | 2008 | 36 | 0.020 |
Why?
|
| Antibodies | 1 | 1988 | 55 | 0.020 |
Why?
|
| src Homology Domains | 1 | 2008 | 16 | 0.020 |
Why?
|
| Glycine | 1 | 2008 | 26 | 0.020 |
Why?
|
| Mice, Inbred BALB C | 1 | 2008 | 199 | 0.020 |
Why?
|
| Photochemistry | 1 | 2008 | 3 | 0.020 |
Why?
|
| Recombinant Fusion Proteins | 1 | 2008 | 122 | 0.020 |
Why?
|
| Oxidation-Reduction | 2 | 2002 | 255 | 0.020 |
Why?
|
| Kidney | 1 | 2011 | 520 | 0.020 |
Why?
|
| Survival Analysis | 1 | 2008 | 478 | 0.020 |
Why?
|
| Antineoplastic Agents | 1 | 2012 | 595 | 0.020 |
Why?
|
| Tissue Engineering | 1 | 2013 | 695 | 0.020 |
Why?
|
| Macaca fascicularis | 1 | 2008 | 542 | 0.020 |
Why?
|
| Factor XIII | 1 | 2006 | 4 | 0.020 |
Why?
|
| Guanidine | 1 | 2006 | 3 | 0.010 |
Why?
|
| Triolein | 1 | 2006 | 3 | 0.010 |
Why?
|
| Dimyristoylphosphatidylcholine | 1 | 2006 | 6 | 0.010 |
Why?
|
| Spodoptera | 1 | 2006 | 5 | 0.010 |
Why?
|
| Peroxisome Proliferator-Activated Receptors | 1 | 2005 | 6 | 0.010 |
Why?
|
| Hydroxyeicosatetraenoic Acids | 1 | 2005 | 4 | 0.010 |
Why?
|
| Prostaglandin D2 | 1 | 2005 | 5 | 0.010 |
Why?
|
| Mitosis | 1 | 2005 | 17 | 0.010 |
Why?
|
| Poly(ADP-ribose) Polymerases | 1 | 2005 | 11 | 0.010 |
Why?
|
| Anilides | 1 | 2005 | 12 | 0.010 |
Why?
|
| Pertussis Toxin | 1 | 2005 | 18 | 0.010 |
Why?
|
| Caspases | 1 | 2005 | 39 | 0.010 |
Why?
|
| Caspase 3 | 1 | 2005 | 36 | 0.010 |
Why?
|
| Prostaglandins E | 1 | 1985 | 3 | 0.010 |
Why?
|
| Epoprostenol | 1 | 1985 | 6 | 0.010 |
Why?
|
| Alprostadil | 1 | 1985 | 3 | 0.010 |
Why?
|
| PPAR gamma | 1 | 2005 | 51 | 0.010 |
Why?
|
| Microspheres | 1 | 1985 | 46 | 0.010 |
Why?
|
| Factor XIIIa | 1 | 2004 | 3 | 0.010 |
Why?
|
| Mechanics | 1 | 2004 | 1 | 0.010 |
Why?
|
| Crystallography | 1 | 2004 | 2 | 0.010 |
Why?
|
| Cell Survival | 1 | 2005 | 286 | 0.010 |
Why?
|
| Bernard-Soulier Syndrome | 2 | 1995 | 2 | 0.010 |
Why?
|
| Tensile Strength | 1 | 2004 | 60 | 0.010 |
Why?
|
| Multiprotein Complexes | 1 | 2004 | 19 | 0.010 |
Why?
|
| Gene Expression | 1 | 2005 | 345 | 0.010 |
Why?
|
| Apoptosis | 1 | 2005 | 367 | 0.010 |
Why?
|
| Transferrin-Binding Proteins | 1 | 2002 | 2 | 0.010 |
Why?
|
| Iron-Binding Proteins | 1 | 2002 | 4 | 0.010 |
Why?
|
| Crystallization | 1 | 2002 | 18 | 0.010 |
Why?
|
| Catalysis | 1 | 2002 | 71 | 0.010 |
Why?
|
| Zinc | 1 | 2002 | 29 | 0.010 |
Why?
|
| Salmonella typhimurium | 1 | 2002 | 36 | 0.010 |
Why?
|
| Enzyme Activation | 1 | 2002 | 133 | 0.010 |
Why?
|
| DNA-Binding Proteins | 1 | 2002 | 149 | 0.010 |
Why?
|
| Amino Acid Substitution | 1 | 2001 | 40 | 0.010 |
Why?
|
| Peroxiredoxins | 1 | 2002 | 117 | 0.010 |
Why?
|
| Molecular Conformation | 1 | 1980 | 11 | 0.010 |
Why?
|
| Immunohistochemistry | 2 | 1994 | 544 | 0.010 |
Why?
|
| Staining and Labeling | 1 | 1980 | 62 | 0.010 |
Why?
|
| Sequence Deletion | 1 | 2000 | 38 | 0.010 |
Why?
|
| Genotype | 1 | 2001 | 706 | 0.010 |
Why?
|
| Spin Labels | 1 | 1999 | 17 | 0.010 |
Why?
|
| Fluorescence | 1 | 1999 | 22 | 0.010 |
Why?
|
| Lasers | 1 | 1997 | 20 | 0.010 |
Why?
|
| Particle Size | 1 | 1997 | 47 | 0.010 |
Why?
|
| Phosphatidylcholine-Sterol O-Acyltransferase | 1 | 1997 | 39 | 0.010 |
Why?
|
| Apolipoprotein A-I | 1 | 1997 | 64 | 0.010 |
Why?
|
| Calcium Chloride | 1 | 1995 | 3 | 0.010 |
Why?
|
| Edetic Acid | 1 | 1995 | 9 | 0.010 |
Why?
|
| Drug Design | 1 | 1995 | 51 | 0.010 |
Why?
|
| Molecular Structure | 1 | 1994 | 58 | 0.010 |
Why?
|
| Anaerobiosis | 1 | 1974 | 1 | 0.010 |
Why?
|
| Optical Rotatory Dispersion | 1 | 1974 | 1 | 0.010 |
Why?
|
| Pepsin A | 1 | 1974 | 5 | 0.010 |
Why?
|
| Guanidines | 1 | 1974 | 7 | 0.010 |
Why?
|
| Hydrogen-Ion Concentration | 1 | 1974 | 67 | 0.010 |
Why?
|
| Sulfhydryl Compounds | 1 | 1974 | 30 | 0.010 |
Why?
|
| Chromatography, Liquid | 1 | 1994 | 33 | 0.010 |
Why?
|
| Cross Reactions | 1 | 1993 | 5 | 0.010 |
Why?
|
| Immunoblotting | 1 | 1993 | 54 | 0.010 |
Why?
|
| Base Sequence | 1 | 1994 | 256 | 0.010 |
Why?
|
| Fluorescent Antibody Technique | 1 | 1993 | 95 | 0.010 |
Why?
|
| Cell Aggregation | 1 | 1992 | 3 | 0.010 |
Why?
|
| Intercellular Junctions | 1 | 1992 | 2 | 0.010 |
Why?
|
| Tissue Distribution | 1 | 1992 | 64 | 0.010 |
Why?
|
| Cell Differentiation | 1 | 1993 | 452 | 0.010 |
Why?
|
| Sodium Dodecyl Sulfate | 1 | 1990 | 5 | 0.010 |
Why?
|
| Phosphatidylethanolamines | 1 | 1990 | 8 | 0.010 |
Why?
|
| Urea | 1 | 1990 | 38 | 0.010 |
Why?
|
| Adenosine Triphosphate | 1 | 1990 | 69 | 0.010 |
Why?
|
| Cell Communication | 1 | 1990 | 36 | 0.000 |
Why?
|